Ad is loading...
MENU

SHTDY Stock Sinopharm Group (SHTDY, $12.93) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 14, 2024

A.I.dvisor
at Tickeron.com
Loading...
SHTDY - Sinopharm Group Co. Ltd.
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $12.93
Daily change: -$0.44 (-3.33%)
Daily volume: 14.6K
Industry: Medical Distributors
This is a Bearish indicator signaling SHTDY's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 47 similar cases where SHTDY's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

Momentum Indicator for SHTDY turns negative, indicating new downward trend

SHTDY saw its Momentum Indicator move below the 0 level on November 21, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In of the 87 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHTDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SHTDY entered a downward trend on November 13, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SHTDY just turned positive on November 12, 2024. Looking at past instances where SHTDY's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for SHTDY moved above the 200-day moving average on November 19, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SHTDY advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.034) is normal, around the industry mean (7.608). P/E Ratio (8.258) is within average values for comparable stocks, (28.511). SHTDY's Projected Growth (PEG Ratio) (10.686) is slightly higher than the industry average of (4.521). Dividend Yield (0.038) settles around the average of (0.032) among similar stocks. P/S Ratio (0.127) is also within normal values, averaging (35.233).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SHTDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHTDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

View a ticker or compare two or three
SHTDY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
No. 385, East Longhua Road
Phone
N/A
Employees
114766
Web
http://www.sinopharmgroup.com.cn